Skin gel offers hope for managing fragile x symptoms in kids
NCT ID NCT03802799
Summary
This study is testing the long-term safety and effects of a CBD gel applied to the skin for children and young adults with Fragile X Syndrome. It is an extension study for up to 550 participants, aged 3 to 18, who were in previous related trials. Parents or caregivers apply the gel twice daily, and researchers will monitor safety and check for changes in symptoms over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE X SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amnova Clinical Research, LLC
Irvine, California, 92604, United States
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Central States Research
Tulsa, Oklahoma, 74136, United States
-
Children's Clinical Research Facility, Royal Hospital for Children and Young People
Edinburgh, Lothian, EH105HF, United Kingdom
-
Children's Hospital of Colorado
Denver, Colorado, 80045, United States
-
Children's Research Institute
Washington D.C., District of Columbia, 20010, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Genetics Clinics Australia
Melbourne, Victoria, 3161, Australia
-
Greenwood Genetic Center
Greenville, South Carolina, 29605, United States
-
Han Phan
Atlanta, Georgia, 30329, United States
-
Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
-
Lady Cilento Children's Hospital - South Brisbane
Brisbane, Queensland, 4101, Australia
-
Manchester University NHS Foundation Trust
Manchester, M13 9WL, United Kingdom
-
Masonic Institute of Developing Brain
Minneapolis, Minnesota, 55414, United States
-
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Primary Children's Hospital
Salt Lake City, Utah, 84113, United States
-
Research Space
Leicester, Leicestershire, LE15WW, United Kingdom
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Science 37
Culver City, California, 90230, United States
-
Southwest Autism Research and Resource Center
Phoenix, Arizona, 85006, United States
-
The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics
New York, New York, 10029, United States
-
UC Davis Health System, MIND Institute
Sacramento, California, 95817, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Mississipi Medical Center
Jackson, Mississippi, 39216, United States
-
Wellington Hospital
Wellington, 6021, New Zealand
-
Westmead Children's Hospital
Sydney, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.